Donghai Jiang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 14
- Drug Transport and Resistance Mechanisms 5
- Pancreatic and Hepatic Oncology Research 3
- Cancer Treatment and Pharmacology 2
-
- Cancer therapeutics and mechanisms 3
- Co-authors
- Lin Zhou (9 shared papers)Weimin Fan (6 shared papers)Danni Chen (3 shared papers)Liang Xu (3 shared papers)Haiyang Xie (8 shared papers)Meihua Sui (3 shared papers)Shusen Zheng (9 shared papers)Xiao Xu (4 shared papers)
- Journals
- Oncology Reports (2 papers)International Journal of Biological Sciences (2 papers)Journal of Translational Medicine (2 papers)Cancer Letters (2 papers)American Journal of Cancer Research (1 paper)
- Partner nations
- ChinaMadagascarUnited States
In The Last Decade
Donghai Jiang
23 papers receiving 681 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 218
- Biomaterials 106
- Oncology 125
- Molecular Biology 342
- Hepatology 22
Countries citing papers authored by Donghai Jiang
This map shows the geographic impact of Donghai Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donghai Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donghai Jiang more than expected).
Fields of papers citing papers by Donghai Jiang
This network shows the impact of papers produced by Donghai Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donghai Jiang. The network helps show where Donghai Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Donghai Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 137 | |
| 2 | 2017 | 82 | |
| 3 | 2019 | 80 | |
| 4 | 2018 | 71 | |
| 5 | 2019 | 52 | |
| 6 | 2013 | 37 | |
| 7 | 2011 | 36 | |
| 8 | 2020 | 31 | |
| 9 | 2009 | 29 | |
| 10 | 2016 | 23 | |
| 11 | Endoplasmic reticulum stress triggers delanzomib-induced apoptosis in HCC cells through the PERK/eIF2α/ATF4/CHOP pathway. | 2020 | 20 |
| 12 | Cabazitaxel, a novel chemotherapeutic alternative for drug-resistant hepatocellular carcinoma. | 2018 | 19 |
| 13 | 2014 | 16 | |
| 14 | Y-320, a novel immune-modulator, sensitizes multidrug-resistant tumors to chemotherapy. | 2020 | 9 |
| 15 | 2023 | 8 | |
| 16 | 2022 | 7 | |
| 17 | The contributions of extrachromosomal DNA elements in neoplasm progression. | 2021 | 6 |
| 18 | 2024 | 5 | |
| 19 | 2016 | 5 | |
| 20 | 2025 | 4 |
About Donghai Jiang
Donghai Jiang is a scholar working on Oncology, Molecular Biology, Biomaterials, Cancer Research and Cell Biology, having authored 23 papers that have together received 687 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Estrogen and related hormone effects (4 papers), Cancer Mechanisms and Therapy (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cancer therapeutics and mechanisms (3 papers), Cancer-related molecular mechanisms research (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Cancer Research (218 citations), Biomaterials (106 citations), Oncology (125 citations), Molecular Biology (342 citations) and Hepatology (22 citations). Donghai Jiang has collaborated with scholars based in China, Madagascar and United States. Frequent co-authors include Lin Zhou, Weimin Fan, Danni Chen, Liang Xu, Haiyang Xie, Meihua Sui, Shusen Zheng, Xiao Xu, Bisha Ding and Weimin Fan. Their work appears in journals such as Oncology Reports, International Journal of Biological Sciences, Journal of Translational Medicine, Cancer Letters and American Journal of Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.